DiaSorin

DiaSorin—publicly listed on the FTSE MIB Index since 2007— is an Italy-based company globally operating in laboratory diagnostics. It develops, produces and markets testing devices and equipment that enable doctors worldwide to make accurate diagnosis. Every second, 10 people in the world encounter DiaSorin.DiaSorin’s success lies in its ongoing biotechnological innovation driven by large-scale investments in research and development. Every year, the Company launches about 10 new diagnostic tests. Research is at the core of the Group’s achievements in the world of laboratory diagnostics. More than 200 employees are committedto developing state-of-the-art specialized testing solutions that assist doctors and laboratory teams in the difficult task of providing effective and efficient results, specifically meeting with their niche testing needs.The choice to develop niche test services alongside more common diagnostic tests has allowed the Group to become a leading player in a very innovative and competitive market and to be internationally recognized as the “Specialist” in the diagnostic field.DiaSorin is present worldwide with 26 companies, 4 branches, 5 production sites and 5 research and development centers. The company operates directly in Europe, Israel, the United States, Canada, Mexico, Brazil, China, India and Australia. The rest of the world is served by more than 200 independent distributors with whom the Group maintains strong relationships in order to offer the best possible service to all its customers.